Cooper Companies (COO) Cash from Investing Activities (2009 - 2026)
Cooper Companies' (COO) quarterly Cash from Investing Activities came in at -$90.0 million in Q2 2026, down 13.64% year-on-year from -$104.2 million in Q2 2025, and up 12.54% quarter-over-quarter from -$102.9 million in Q1 2026.
Cooper Companies (COO) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Cooper Companies' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$90.0 million for Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 13.64% year-over-year to -$90.0 million in Q2 2026; TTM through Apr 2026 was -$389.8 million, a 28.04% increase from a year earlier, with the FY2025 full-year figure at -$372.9 million, up 51.23% from the prior year.
- Cash from Investing Activities grew to -$90.0 million in Q2 2026 per COO's latest filing, from -$102.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$15.7 million in Q2 2022 and bottomed at -$1.7 billion in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$98.4 million (2025), against an average of -$200.6 million.
- Across the five-year window, Cash from Investing Activities tumbled 1130.14% in 2022 and surged 93.21% in 2023, its largest moves.
- Year by year, Cash from Investing Activities stood at -$99.7 million in 2022, then tumbled by 61.28% to -$160.8 million in 2023, then plunged by 50.25% to -$241.6 million in 2024, then surged by 59.11% to -$98.8 million in 2025, then gained by 8.91% to -$90.0 million in 2026.
- Per Business Quant, the three latest COO Cash from Investing Activities figures stand at -$90.0 million (Q2 2026), -$102.9 million (Q1 2026), and -$98.8 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.97 Bn | 120.75 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.74 Bn | 43.93 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.94 Bn | 31.28 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.60 Bn | 23.16 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 13.99 Bn | 13.43 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.76 Bn | 13.62 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 11.94 Bn | 9.93 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -90.00 Mn |
| Apr 30, 2026 | -90.00 Mn |
| Jan 31, 2026 | -102.90 Mn |
| Jan 31, 2026 | -102.90 Mn |
| Oct 31, 2025 | -98.80 Mn |
| Oct 31, 2025 | -98.80 Mn |
| Jul 31, 2025 | -98.10 Mn |
| Jul 31, 2025 | -98.10 Mn |
| Apr 30, 2025 | -79.20 Mn |
| Apr 30, 2025 | -79.20 Mn |
| Jan 31, 2025 | -96.80 Mn |
| Jan 31, 2025 | -96.80 Mn |
| Oct 31, 2024 | -241.60 Mn |
| Oct 31, 2024 | -241.60 Mn |
| Jul 31, 2024 | -124.10 Mn |
| Jul 31, 2024 | -124.10 Mn |
| Apr 30, 2024 | -74.80 Mn |
| Apr 30, 2024 | -74.80 Mn |
| Jan 31, 2024 | -324.10 Mn |
| Jan 31, 2024 | -324.10 Mn |